耳鼻咽喉科疾患の治療の世界市場：インサイト・予測

• 英文タイトル：Global ENT Disorder Treatment Market Insights, Forecast to 2025

• レポートコード：QYR9ST00464
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、113ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートでは、世界の耳鼻咽喉科疾患の治療市場について調査・分析し、以下の構成でお届け致します。耳鼻咽喉科疾患の治療の種類別には、扁桃炎、耳の感染症、副鼻腔感染症、睡眠時無呼吸に、用途別には、病院、診療所、外来手術センター、在宅ケア設定、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別耳鼻咽喉科疾患の治療売上データ
・地域別耳鼻咽喉科疾患の治療市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別耳鼻咽喉科疾患の治療市場規模：扁桃炎、耳の感染症、副鼻腔感染症、睡眠時無呼吸
・用途別耳鼻咽喉科疾患の治療市場規模：病院、診療所、外来手術センター、在宅ケア設定、その他
・主要メーカーの企業情報：AstraZeneca、Novartis、Pfizer、Mylan、Teva Pharmaceutical、GlaxoSmithKline、Otonomy、Merck、Reddy’s、Allergen
・耳鼻咽喉科疾患の治療の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...

ENT is a medical abbreviation for ears, nose and throat.Major factor contributing to growth of the global ENT disorder treatment market includes increasing pollution.
The global ENT Disorder Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the ENT Disorder Treatment market based on company, product type, end user and key regions.

This report studies the global market size of ENT Disorder Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of ENT Disorder Treatment in these regions.
This research report categorizes the global ENT Disorder Treatment market by top players/brands, region, type and end user. This report also studies the global ENT Disorder Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca
Novartis
Pfizer
Mylan
Teva Pharmaceutical
GlaxoSmithKline
Otonomy
Merck
Reddy’s
Allergen

Market size by Product
Tonsillitis
Ear Infections
Sinus Infections
Sleep Apnea
Market size by End User
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global ENT Disorder Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of ENT Disorder Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global ENT Disorder Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of ENT Disorder Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of ENT Disorder Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of ENT Disorder Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Study Coverage
1.1 ENT Disorder Treatment Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global ENT Disorder Treatment Market Size Growth Rate by Product
1.4.2 Tonsillitis
1.4.3 Ear Infections
1.4.4 Sinus Infections
1.4.5 Sleep Apnea
1.5 Market by End User
1.5.1 Global ENT Disorder Treatment Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Home Care Settings
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global ENT Disorder Treatment Market Size
2.1.1 Global ENT Disorder Treatment Revenue 2014-2025
2.1.2 Global ENT Disorder Treatment Sales 2014-2025
2.2 ENT Disorder Treatment Growth Rate by Regions
2.2.1 Global ENT Disorder Treatment Sales by Regions
2.2.2 Global ENT Disorder Treatment Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 ENT Disorder Treatment Sales by Manufacturers
3.1.1 ENT Disorder Treatment Sales by Manufacturers
3.1.2 ENT Disorder Treatment Sales Market Share by Manufacturers
3.1.3 Global ENT Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.2 ENT Disorder Treatment Revenue by Manufacturers
3.2.1 ENT Disorder Treatment Revenue by Manufacturers (2014-2019)
3.2.2 ENT Disorder Treatment Revenue Share by Manufacturers (2014-2019)
3.3 ENT Disorder Treatment Price by Manufacturers
3.4 ENT Disorder Treatment Manufacturing Base Distribution, Product Types
3.4.1 ENT Disorder Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers ENT Disorder Treatment Product Type
3.4.3 Date of International Manufacturers Enter into ENT Disorder Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global ENT Disorder Treatment Sales by Product
4.2 Global ENT Disorder Treatment Revenue by Product
4.3 ENT Disorder Treatment Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global ENT Disorder Treatment Breakdown Data by End User

6 North America
6.1 North America ENT Disorder Treatment by Countries
6.1.1 North America ENT Disorder Treatment Sales by Countries
6.1.2 North America ENT Disorder Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America ENT Disorder Treatment by Product
6.3 North America ENT Disorder Treatment by End User

7 Europe
7.1 Europe ENT Disorder Treatment by Countries
7.1.1 Europe ENT Disorder Treatment Sales by Countries
7.1.2 Europe ENT Disorder Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe ENT Disorder Treatment by Product
7.3 Europe ENT Disorder Treatment by End User

8 Asia Pacific
8.1 Asia Pacific ENT Disorder Treatment by Countries
8.1.1 Asia Pacific ENT Disorder Treatment Sales by Countries
8.1.2 Asia Pacific ENT Disorder Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific ENT Disorder Treatment by Product
8.3 Asia Pacific ENT Disorder Treatment by End User

9 Central & South America
9.1 Central & South America ENT Disorder Treatment by Countries
9.1.1 Central & South America ENT Disorder Treatment Sales by Countries
9.1.2 Central & South America ENT Disorder Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America ENT Disorder Treatment by Product
9.3 Central & South America ENT Disorder Treatment by End User

10 Middle East and Africa
10.1 Middle East and Africa ENT Disorder Treatment by Countries
10.1.1 Middle East and Africa ENT Disorder Treatment Sales by Countries
10.1.2 Middle East and Africa ENT Disorder Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa ENT Disorder Treatment by Product
10.3 Middle East and Africa ENT Disorder Treatment by End User

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Business Overview
11.1.3 AstraZeneca ENT Disorder Treatment Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AstraZeneca ENT Disorder Treatment Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Business Overview
11.2.3 Novartis ENT Disorder Treatment Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis ENT Disorder Treatment Products Offered
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer ENT Disorder Treatment Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer ENT Disorder Treatment Products Offered
11.3.5 Pfizer Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Company Business Overview
11.4.3 Mylan ENT Disorder Treatment Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Mylan ENT Disorder Treatment Products Offered
11.4.5 Mylan Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Details
11.5.2 Company Business Overview
11.5.3 Teva Pharmaceutical ENT Disorder Treatment Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Teva Pharmaceutical ENT Disorder Treatment Products Offered
11.5.5 Teva Pharmaceutical Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 Company Business Overview
11.6.3 GlaxoSmithKline ENT Disorder Treatment Sales, Revenue and Gross Margin (2014-2019)
11.6.4 GlaxoSmithKline ENT Disorder Treatment Products Offered
11.6.5 GlaxoSmithKline Recent Development
11.7 Otonomy
11.7.1 Otonomy Company Details
11.7.2 Company Business Overview
11.7.3 Otonomy ENT Disorder Treatment Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Otonomy ENT Disorder Treatment Products Offered
11.7.5 Otonomy Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Company Business Overview
11.8.3 Merck ENT Disorder Treatment Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Merck ENT Disorder Treatment Products Offered
11.8.5 Merck Recent Development
11.9 Reddy’s
11.9.1 Reddy’s Company Details
11.9.2 Company Business Overview
11.9.3 Reddy’s ENT Disorder Treatment Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Reddy’s ENT Disorder Treatment Products Offered
11.9.5 Reddy’s Recent Development
11.10 Allergen
11.10.1 Allergen Company Details
11.10.2 Company Business Overview
11.10.3 Allergen ENT Disorder Treatment Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Allergen ENT Disorder Treatment Products Offered
11.10.5 Allergen Recent Development

12 Future Forecast
12.1 ENT Disorder Treatment Market Forecast by Regions
12.1.1 Global ENT Disorder Treatment Sales Forecast by Regions 2019-2025
12.1.2 Global ENT Disorder Treatment Revenue Forecast by Regions 2019-2025
12.2 ENT Disorder Treatment Market Forecast by Product
12.2.1 Global ENT Disorder Treatment Sales Forecast by Product 2019-2025
12.2.2 Global ENT Disorder Treatment Revenue Forecast by Product 2019-2025
12.3 ENT Disorder Treatment Market Forecast by End User
12.4 North America ENT Disorder Treatment Forecast
12.5 Europe ENT Disorder Treatment Forecast
12.6 Asia Pacific ENT Disorder Treatment Forecast
12.7 Central & South America ENT Disorder Treatment Forecast
12.8 Middle East and Africa ENT Disorder Treatment Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 ENT Disorder Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure ENT Disorder Treatment Product Picture
Table ENT Disorder Treatment Market Segments
Table Key Manufacturers ENT Disorder Treatment Covered
Table Global ENT Disorder Treatment Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global ENT Disorder Treatment Sales Market Share by Product 2014-2025
Figure Tonsillitis Product Picture
Table Major Manufacturers of Tonsillitis
Figure Ear Infections Product Picture
Table Major Manufacturers of Ear Infections
Figure Sinus Infections Product Picture
Table Major Manufacturers of Sinus Infections
Figure Sleep Apnea Product Picture
Table Major Manufacturers of Sleep Apnea
Table Global ENT Disorder Treatment Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Ambulatory Surgical Centers
Figure Home Care Settings
Figure Others
Figure ENT Disorder Treatment Report Years Considered
Figure Global ENT Disorder Treatment Market Size 2014-2025 (Million US$)
Figure Global ENT Disorder Treatment Sales 2014-2025 (K Units)
Table Global ENT Disorder Treatment Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global ENT Disorder Treatment Sales by Regions 2014-2019 (K Units)
Table Global ENT Disorder Treatment Sales Market Share by Regions 2014-2019
Figure Global ENT Disorder Treatment Sales Market Share by Regions 2014-2019
Figure 2018 Global ENT Disorder Treatment Sales Market Share by Regions
Table Global ENT Disorder Treatment Revenue by Regions 2014-2019 (Million US$)
Table Global ENT Disorder Treatment Revenue Market Share by Regions 2014-2019
Figure Global ENT Disorder Treatment Revenue Market Share by Regions 2014-2019
Figure 2018 Global ENT Disorder Treatment Revenue Market Share by Regions
Table Global ENT Disorder Treatment Sales by Manufacturers (2014-2019) (K Units)
Table Global ENT Disorder Treatment Sales Share by Manufacturers (2014-2019)
Figure Global ENT Disorder Treatment Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table ENT Disorder Treatment Revenue by Manufacturers (2014-2019) (Million USD)
Table ENT Disorder Treatment Revenue Share by Manufacturers (2014-2019)
Figure ENT Disorder Treatment Value Share by Manufacturers in 2018
Table Key Manufacturers ENT Disorder Treatment Price (2014-2019) (USD/Unit)
Table ENT Disorder Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers ENT Disorder Treatment Product Type
Table Date of International Manufacturers Enter into ENT Disorder Treatment Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global ENT Disorder Treatment Sales by Product (2014-2019) (K Units)
Table Global ENT Disorder Treatment Sales Share by Product (2014-2019)
Figure Global ENT Disorder Treatment Sales Market Share by Product (2014-2019)
Figure Global ENT Disorder Treatment Sales Market Share by Product in 2018
Table Global ENT Disorder Treatment Revenue by Product (2014-2019) (Million US$)
Table Global ENT Disorder Treatment Revenue Share by Product (2014-2019)
Figure Global ENT Disorder Treatment Revenue Market Share by Product (2014-2019)
Figure Global ENT Disorder Treatment Revenue Market Share by Product in 2018
Table ENT Disorder Treatment Price by Product 2014-2019 (USD/Unit)
Table Global ENT Disorder Treatment Sales by End User (2014-2019) (K Units)
Table Global ENT Disorder Treatment Sales Share by End User (2014-2019)
Figure Global Sales ENT Disorder Treatment Market Share by End User (2014-2019)
Figure Global Sales ENT Disorder Treatment Market Share by End User in 2018
Figure North America ENT Disorder Treatment Sales Growth Rate 2014-2019 (K Units)
Figure North America ENT Disorder Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table North America ENT Disorder Treatment Sales by Countries (2014-2019) (K Units)
Table North America ENT Disorder Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 North America ENT Disorder Treatment Sales Market Share by Countries
Table North America ENT Disorder Treatment Revenue by Countries (2014-2019) (Million US$)
Table North America ENT Disorder Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 North America ENT Disorder Treatment Revenue Market Share by Countries
Figure United States ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure United States ENT Disorder Treatment Revenue Growth Rate (2014-2019) (K Units)
Figure Canada ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Canada ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Mexico ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table North America ENT Disorder Treatment Sales by Product (2014-2019) (K Units)
Table North America ENT Disorder Treatment Sales Market Share by Product (2014-2019)
Figure 2018 North America ENT Disorder Treatment Market Share by Product
Table North America ENT Disorder Treatment Sales by End User (2014-2019) (K Units)
Table North America ENT Disorder Treatment Sales Market Share by End User (2014-2019)
Figure 2018 North America ENT Disorder Treatment Market Share by End User
Figure Europe ENT Disorder Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Europe ENT Disorder Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Europe ENT Disorder Treatment Sales by Countries (2014-2019) (K Units)
Table Europe ENT Disorder Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Europe ENT Disorder Treatment Sales Market Share by Countries
Table Europe ENT Disorder Treatment Revenue by Countries (2014-2019) (Million US$)
Table Europe ENT Disorder Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe ENT Disorder Treatment Revenue Market Share by Countries
Figure Germany ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Germany ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure France ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure France ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure UK ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure UK ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Italy ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Russia ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Europe ENT Disorder Treatment Sales by Product (2014-2019) (K Units)
Table Europe ENT Disorder Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Europe ENT Disorder Treatment Market Share by Product
Table Europe ENT Disorder Treatment Sales by End User (2014-2019) (K Units)
Table Europe ENT Disorder Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Europe ENT Disorder Treatment Market Share by End User
Figure Asia Pacific ENT Disorder Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific ENT Disorder Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific ENT Disorder Treatment Sales by Countries (2014-2019) (K Units)
Table Asia Pacific ENT Disorder Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific ENT Disorder Treatment Sales Market Share by Countries
Table Asia Pacific ENT Disorder Treatment Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific ENT Disorder Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific ENT Disorder Treatment Revenue Market Share by Countries
Figure China ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure China ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Japan ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Korea ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure India ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure India ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Australia ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Philippines ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Thailand ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Singapore ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific ENT Disorder Treatment Sales by Product (2014-2019) (K Units)
Table Asia Pacific ENT Disorder Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific ENT Disorder Treatment Market Share by Product
Table Asia Pacific ENT Disorder Treatment Sales by End User (2014-2019) (K Units)
Table Asia Pacific ENT Disorder Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific ENT Disorder Treatment Market Share by End User
Figure Central & South America ENT Disorder Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America ENT Disorder Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America ENT Disorder Treatment Sales by Countries (2014-2019) (K Units)
Table Central & South America ENT Disorder Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America ENT Disorder Treatment Sales Market Share by Countries
Table Central & South America ENT Disorder Treatment Revenue by Countries (2014-2019) (Million US$)
Table Central & South America ENT Disorder Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America ENT Disorder Treatment Revenue Market Share by Countries
Figure Brazil ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Brazil ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Argentina ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America ENT Disorder Treatment Sales by Product (2014-2019) (K Units)
Table Central & South America ENT Disorder Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America ENT Disorder Treatment Market Share by Product
Table Central & South America ENT Disorder Treatment Sales by End User (2014-2019) (K Units)
Table Central & South America ENT Disorder Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America ENT Disorder Treatment Market Share by End User
Figure Middle East and Africa ENT Disorder Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa ENT Disorder Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa ENT Disorder Treatment Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa ENT Disorder Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa ENT Disorder Treatment Sales Market Share by Countries
Table Middle East and Africa ENT Disorder Treatment Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa ENT Disorder Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa ENT Disorder Treatment Revenue Market Share by Countries
Figure GCC Countries ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Turkey ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Egypt ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa ENT Disorder Treatment Sales Growth Rate (2014-2019) (K Units)
Figure South Africa ENT Disorder Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa ENT Disorder Treatment Sales by Product (2014-2019) (K Units)
Table Middle East and Africa ENT Disorder Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa ENT Disorder Treatment Market Share by Product
Table Middle East and Africa ENT Disorder Treatment Sales by End User (2014-2019) (K Units)
Table Middle East and Africa ENT Disorder Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa ENT Disorder Treatment Market Share by End User
Table AstraZeneca Company Details
Table AstraZeneca ENT Disorder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development

Table Novartis Company Details
Table Novartis ENT Disorder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development

Table Pfizer Company Details
Table Pfizer ENT Disorder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Mylan Company Details
Table Mylan ENT Disorder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Recent Development

Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical ENT Disorder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Recent Development

Table GlaxoSmithKline Company Details
Table GlaxoSmithKline ENT Disorder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development

Table Otonomy Company Details
Table Otonomy ENT Disorder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Otonomy Recent Development

Table Merck Company Details
Table Merck ENT Disorder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development

Table Reddy’s Company Details
Table Reddy’s ENT Disorder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Reddy’s Recent Development

Table Allergen Company Details
Table Allergen ENT Disorder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergen Recent Development

Table Global ENT Disorder Treatment Sales Forecast by Regions 2019-2025 (K Units)
Table Global ENT Disorder Treatment Sales Market Share Forecast by Regions 2019-2025
Table Global ENT Disorder Treatment Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global ENT Disorder Treatment Revenue Market Share Forecast by Regions 2019-2025
Table Global ENT Disorder Treatment Sales Forecast by Product 2019-2025 (K Units)
Table Global ENT Disorder Treatment Sales Market Share Forecast by Product 2019-2025
Table Global ENT Disorder Treatment Revenue Forecast by Product 2019-2025 (Million US$)
Table Global ENT Disorder Treatment Revenue Market Share Forecast by Product 2019-2025
Table Global ENT Disorder Treatment Sales Forecast by End User 2019-2025 (K Units)
Table Global ENT Disorder Treatment Sales Market Share Forecast by End User 2019-2025
Figure North America ENT Disorder Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America ENT Disorder Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe ENT Disorder Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe ENT Disorder Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific ENT Disorder Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific ENT Disorder Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America ENT Disorder Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America ENT Disorder Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa ENT Disorder Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa ENT Disorder Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table ENT Disorder Treatment Value Chain
Table ENT Disorder Treatment Customers List
Table ENT Disorder Treatment Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

甲状腺障害治療の世界市場：市場規模・現状・予測

Global Thyroid Gland Disorder Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04561 2019年9月2日 99Pages
※当調査レポートでは、甲状腺障害治療の世界市場について調査・分析し、甲状腺障害治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（甲状腺機能亢進症、甲状腺機能低下症、その他）、用途別（男性、女性）、...

胎児アルコールスペクトラム障害治療の世界市場：市場規模・現状・予測

Global Fetal Alcohol Spectrum Disorder Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04455 2019年9月2日 90Pages
※当調査レポートでは、胎児アルコールスペクトラム障害治療の世界市場について調査・分析し、胎児アルコールスペクトラム障害治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗うつ剤、興奮剤、神経弛緩薬...

認知症および運動障害の治療の世界市場：市場規模・現状・予測

Global Dementia and Movement Disorder Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04433 2019年9月2日 95Pages
※当調査レポートでは、認知症および運動障害の治療の世界市場について調査・分析し、認知症および運動障害の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（MAO阻害剤（モノアミンオキシダーゼ）、AC...

睡眠障害モニタリングの世界市場：インサイト・予測

Global Sleep Disorder Monitoring Market Insights, Forecast to 2025
QYR9ST01176 2019年9月2日 118Pages
※本調査レポートでは、世界の睡眠障害モニタリング市場について調査・分析し、以下の構成でお届け致します。睡眠障害モニタリングの種類別には、タイプI睡眠モニター、タイプII睡眠モニター、タイプIII睡眠モニター、タイプIV睡眠モニターに、用途別には、病院、睡眠センター、在宅ケアに、地域別には、北米、アメ...

心的外傷後ストレス障害（PTSD）治療薬の世界市場：インサイト・予測

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Insights, Forecast to 2025
QYR9ST02997 2019年9月2日 117Pages
※本調査レポートでは、世界の心的外傷後ストレス障害（PTSD）治療薬市場について調査・分析し、以下の構成でお届け致します。心的外傷後ストレス障害（PTSD）治療薬の種類別には、抗うつ薬、抗不安薬に、用途別には、病院、薬局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国...

オピオイド使用障害の世界市場：市場規模・現状・予測

Global Opioid Use Disorder Market Size, Status and Forecast 2019-2025
QYR9ST14561 2019年9月10日 97Pages
※当調査レポートでは、オピオイド使用障害の世界市場について調査・分析し、オピオイド使用障害の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ブプレノルフィン、メタドン、ナルトレキソン）、用途別（中等度...

神経芽腫治療の世界市場：インサイト・予測

Global Neuroblastoma Treatment Market Insights, Forecast to 2025
QYR9ST01633 2019年9月2日 119Pages
※本調査レポートでは、世界の神経芽腫治療市場について調査・分析し、以下の構成でお届け致します。神経芽腫治療の種類別には、併用化学療法、モノクローナル抗体療法、ワクチン療法、その他に、用途別には、病院、診療所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南...

髄膜炎菌性疾患治療の世界市場：インサイト・予測

Global Meningococcal Disease Treatment Market Insights, Forecast to 2025
QYR9ST02947 2019年9月2日 119Pages
※本調査レポートでは、世界の髄膜炎菌性疾患治療市場について調査・分析し、以下の構成でお届け致します。髄膜炎菌性疾患治療の種類別には、抗生物質、ワクチンに、用途別には、病院、ドラッグストア、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカな...

甲状腺障害の世界市場：市場規模・現状・予測

Global Thyroid Disorder Market Size, Status and Forecast 2019-2025
QYR9ST05057 2019年9月2日 92Pages
※当調査レポートでは、甲状腺障害の世界市場について調査・分析し、甲状腺障害の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（甲状腺機能低下症、甲状腺機能亢進症）、用途別（病院、クリニック、その他）、地...

甲状腺障害の世界市場：市場規模・現状・予測

睡眠障害モニタリングの世界市場：インサイト・予測 A sleep disorder, or somnipathy, is a medical disorder of the sleep patterns of a person or animal. Some sleep disorders are serious enough to interfere with normal physical, mental, social and emotional functioning. Polysomnography and actigraphy are tests commonly ordered for some sleep disorders.…
甲状腺障害治療の世界市場：市場規模・現状・予測 Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect major…
認知症および運動障害の治療の世界市場：市場規模・現状・予測 Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality change…
胎児アルコールスペクトラム障害治療の世界市場：市場規模・現状・予測 Fetal alcohol spectrum disorder are the group of conditions occurring in new born with a wide range of disabilities.Fetal alcohol spectrum disorder treatment market is an evolving market owing to the gradual change in the lifestyle and increased alcohol consumption by pregnant women, eventually incr…
壊死性皮膚感染症治療の世界市場：市場規模・現状・予測 Necrotizing skin infections ranks among the most rarely found diseases but are highly lethal infection. Necrotizing skin infection arise primarily in any layer of skin soft tissue such as dermis and epidermis that are associated with necrotizing changes. Necrotizing skin infection is also commonly c…